IL97429A - History of N-Tufen-Ura Transformed Preparation and Pharmaceutical Preparations Containing Them - Google Patents

History of N-Tufen-Ura Transformed Preparation and Pharmaceutical Preparations Containing Them

Info

Publication number
IL97429A
IL97429A IL9742991A IL9742991A IL97429A IL 97429 A IL97429 A IL 97429A IL 9742991 A IL9742991 A IL 9742991A IL 9742991 A IL9742991 A IL 9742991A IL 97429 A IL97429 A IL 97429A
Authority
IL
Israel
Prior art keywords
compound
formula
oxadiazol
urea
ailment
Prior art date
Application number
IL9742991A
Other languages
English (en)
Hebrew (he)
Other versions
IL97429A0 (en
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL97429A0 publication Critical patent/IL97429A0/xx
Publication of IL97429A publication Critical patent/IL97429A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Treating Waste Gases (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Cephalosporin Compounds (AREA)
IL9742991A 1990-02-16 1991-03-05 History of N-Tufen-Ura Transformed Preparation and Pharmaceutical Preparations Containing Them IL97429A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK040890A DK40890D0 (da) 1990-02-16 1990-02-16 Substituerede urinstofforbindelser, deres fremstilling og anvendelse

Publications (2)

Publication Number Publication Date
IL97429A0 IL97429A0 (en) 1992-06-21
IL97429A true IL97429A (en) 1996-01-31

Family

ID=8093190

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9742991A IL97429A (en) 1990-02-16 1991-03-05 History of N-Tufen-Ura Transformed Preparation and Pharmaceutical Preparations Containing Them

Country Status (15)

Country Link
US (2) US5187164A (de)
EP (1) EP0515537B1 (de)
JP (1) JPH05504358A (de)
AT (1) ATE156128T1 (de)
AU (1) AU648066B2 (de)
CA (1) CA2074803A1 (de)
DE (1) DE69127072T2 (de)
DK (1) DK40890D0 (de)
FI (1) FI923475A0 (de)
IE (1) IE910523A1 (de)
IL (1) IL97429A (de)
NZ (1) NZ237122A (de)
PT (1) PT96788B (de)
WO (1) WO1991012254A1 (de)
ZA (1) ZA911103B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530008A (en) * 1989-04-21 1996-06-25 Sandoz Ltd. Use of 5-HT3 receptor antagonists in treating panic disorders or obsessive compulsive disorders
DK443489D0 (da) * 1989-09-08 1989-09-08 Ferrosan As Substituerede urinstofforbindelser, deres fremstilling og anvendelse
GB9214184D0 (en) * 1992-07-03 1992-08-12 Smithkline Beecham Plc Pharmaceuticals
US5663182A (en) * 1993-08-19 1997-09-02 Bymaster; Franklin Porter Antipsychotic method
US6953855B2 (en) * 1998-12-11 2005-10-11 Targacept, Inc. 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
WO2001095902A1 (en) * 2000-06-15 2001-12-20 Respiratorius Ab A composition comprising a combination of receptor agonists and antagonists
CN100364531C (zh) * 2002-12-18 2008-01-30 西托维亚公司 3,5－二取代－[1,2,4]－二唑及类似物和其用途
ES2297490T3 (es) 2003-07-23 2008-05-01 Bayer Pharmaceuticals Corporation Omega-carboxiarildifenilurea fluoro sustituida para el tratamiento y prevencion de enfermadades y afecciones.
SA08290475B1 (ar) 2007-08-02 2013-06-22 Targacept Inc (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
TW201031664A (en) 2009-01-26 2010-09-01 Targacept Inc Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
JPWO2014051055A1 (ja) * 2012-09-28 2016-08-22 東レ株式会社 キヌクリジンウレア誘導体及びその医薬用途
US9724340B2 (en) 2015-07-31 2017-08-08 Attenua, Inc. Antitussive compositions and methods

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4003904A (en) * 1974-04-01 1977-01-18 G. D. Searle & Co. Anti-diarrheal oxadiazoles
US3917615A (en) * 1974-04-01 1975-11-04 Searle & Co 1,1-Diaryl-1-oxadiazol-alkylamines
CH614709A5 (de) * 1975-09-25 1979-12-14 Ciba Geigy Ag
US4012393A (en) * 1976-03-22 1977-03-15 G. D. Searle & Co. 2-[5-(CYCLIC AMINO) ETHYL-10,11-DIHYDRO-5H-dibenzo[a,d]-cyclohepten-5- yl]-5
EP0235878A3 (de) * 1986-01-16 1989-06-14 Beecham Group Plc Neue Verbindungen
DE3785507T2 (de) * 1986-07-31 1993-07-29 Beecham Group Plc Azabicyclische verbindungen, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
IE63906B1 (en) * 1987-11-13 1995-06-14 Novo Nordisk As Azabicyclic compounds and their preparation and use
AU611976B2 (en) * 1987-12-24 1991-06-27 John Wyeth & Brother Limited Aroyl urea and carbamic acid derivatives of azabicyclo compounds
US4863921A (en) * 1988-04-27 1989-09-05 Rorer Pharmaceutical Corporation Dibenzofurancarboxamides and their pharmaceutical compositions and methods
DK443489D0 (da) * 1989-09-08 1989-09-08 Ferrosan As Substituerede urinstofforbindelser, deres fremstilling og anvendelse

Also Published As

Publication number Publication date
PT96788A (pt) 1991-10-31
FI923475A (fi) 1992-07-31
AU648066B2 (en) 1994-04-14
DE69127072D1 (de) 1997-09-04
ZA911103B (en) 1991-11-27
US5187164A (en) 1993-02-16
EP0515537A1 (de) 1992-12-02
NZ237122A (en) 1993-02-25
CA2074803A1 (en) 1991-08-17
DE69127072T2 (de) 1998-01-22
DK40890D0 (da) 1990-02-16
EP0515537B1 (de) 1997-07-30
JPH05504358A (ja) 1993-07-08
IE910523A1 (en) 1991-08-28
IL97429A0 (en) 1992-06-21
PT96788B (pt) 1998-07-31
US5290795A (en) 1994-03-01
WO1991012254A1 (en) 1991-08-22
ATE156128T1 (de) 1997-08-15
FI923475A0 (fi) 1992-07-31
AU7340991A (en) 1991-09-03

Similar Documents

Publication Publication Date Title
AU642178B2 (en) New tricyclic compounds
US5491148A (en) Isoquinolinone and dihydroisoquinolinone 5-HT3 receptor antagonists
US5330990A (en) Substituted urea compounds and their preparation and use
US4816453A (en) N-heterocyclic derivatives of benzamides and their use in treating gastric and intestinal disorders
IE914247A1 (en) Ó-Oxoacetamide Derivatives
IE58313B1 (en) Azabicyclononyl-indazole-carboxamide having 5-ht antagonist activity
EP0515537B1 (de) Substituierte harnstoffe, herstellung und verwendung
EP1562945A1 (de) 1,4-dizabicyclo(3,2,2)nonane derivative, verfahren zur ihre herstellung und therapeutical verwendung
WO1989010364A1 (en) Dibenzofurancarboxamides
IE913987A1 (en) New tricyclic compounds
AU658533B2 (en) Piperidine derivatives, their preparation and their application in therapy
US5202318A (en) Tricyclic compounds acting at serotonin receptor subtypes
NZ241019A (en) Azabicyclic-substituted benzoic acid or benzamide derivatives and pharmaceutical compositions
US5246942A (en) Pharmaceutically useful dibenzofurancarboxamides of specific stereo-configuration
IE911627A1 (en) Novel tricyclic compounds
EP0611370A1 (de) Pyridine-3-carbonsäure esters oder amide nützlich als 5ht3 antagonisten
Berger et al. Tricyclic 5-HT 3 receptor antagonists
WO1991004738A1 (en) Dibenzofurancarboxamides

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees